Abstract
The sensitivity of a hormone-independent human prostatic carcinoma cell line (PC-3) to anticancer drugs was evaluated in vitro. The anticancer drugs used were vincristine sulfate (VCR), peplomycin sulfate (PLM) and 4-hydroperoxyisophosphamide (4-HIF), i.e., an form of ifosfamide (IFOS) in vivo. The inhibitory effect of 4-HIF alone and of the combination of VCR, 4-HIF and PLM (VIP) on the cell proliferation was almost the same. Furthermore, among the 6 groups treated with 2 of the 3 drugs mentioned above the most potent inhibitory effect was obtained in the group with combined treatment of 4-HIF plus PLM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
